Literature DB >> 35859635

Recurrent Optic Neuritis in Paediatric Anti-N-Methyl-D-Aspartate Receptor (Anti-NMDAR) Encephalitis: Case Report and Literature Review.

Jinn Shian Chan1,2, Masnon Nurul-Ain2,3, Nor Fadhilah Mohamad1, Wan Hazabbah Wan Hitam3, Lakana Kumar Thavaratnam2.   

Abstract

Optic neuritis associated with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis poses a novel challenge and is recognised as being part of overlapping antibody-associated demyelinating syndromes. We report a case of a 10-year-old girl who first presented with anti-NMDAR encephalitis and later developed four episodes of left optic neuritis. Blurring of vision, pain on eye movement, and headache were the striking features in all episodes of optic neuritis. For each recurrent episode of optic neuritis she was treated with intravenous methylprednisolone, following which visual acuity, colour vision, and visual field improved to normal. Neuroimaging was unremarkable. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibody tests were negative. She developed a relapse of anti-NMDAR encephalitis after recurrent episodes of optic neuritis despite being on azathioprine. Intravenous immunoglobulin and cycles of cyclophosphamide were started, and she has been free from optic neuritis and encephalitis for more than one year since. Optic neuritis and anti-NMDAR encephalitis are reversible with intensive immunotherapy. Early and accurate diagnosis can lead to better management of this condition.
© 2021 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Encephalitis; N-methyl-D-aspartate receptor; optic disc drusen; optic neuritis

Year:  2022        PMID: 35859635      PMCID: PMC9291683          DOI: 10.1080/01658107.2021.2014892

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  16 in total

1.  NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.

Authors:  M C Kruer; T K Koch; D N Bourdette; D Chabas; E Waubant; S Mueller; M A Moscarello; J Dalmau; R L Woltjer; G Adamus
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

2.  Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies.

Authors:  Eugenia Martinez-Hernandez; Mar Guasp; Anna García-Serra; Estibaliz Maudes; Helena Ariño; Maria Sepulveda; Thaís Armangué; Ana P Ramos; Tamir Ben-Hur; Takahiro Iizuka; Albert Saiz; Francesc Graus; Josep Dalmau
Journal:  Neurology       Date:  2020-03-11       Impact factor: 9.910

3.  Live-cell based assays are the gold standard for anti-MOG-Ab testing.

Authors:  E Ann Yeh; Ichiro Nakashima
Journal:  Neurology       Date:  2019-02-06       Impact factor: 9.910

4.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

5.  Influence of retinal NMDA receptor activity during autoimmune optic neuritis.

Authors:  Jovana Bojcevski; Aleksandar Stojic; Dorit B Hoffmann; Sarah K Williams; Andreas Müller; Ricarda Diem; Richard Fairless
Journal:  J Neurochem       Date:  2020-03-03       Impact factor: 5.372

6.  Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.

Authors:  Thaís Armangue; Gemma Olivé-Cirera; Eugenia Martínez-Hernandez; Maria Sepulveda; Raquel Ruiz-Garcia; Marta Muñoz-Batista; Helena Ariño; Veronica González-Álvarez; Ana Felipe-Rucián; Maria Jesús Martínez-González; Veronica Cantarín-Extremera; Maria Concepción Miranda-Herrero; Lorena Monge-Galindo; Miguel Tomás-Vila; Elena Miravet; Ignacio Málaga; Georgina Arrambide; Cristina Auger; Mar Tintoré; Xavier Montalban; Adeline Vanderver; Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Lancet Neurol       Date:  2020-02-10       Impact factor: 44.182

7.  [Anti-NMDA receptor antibody encephalitis with recurrent optic neuritis and epilepsy].

Authors:  Rie Motoyama; Kazuhiro Shiraishi; Keiko Tanaka; Masako Kinoshita; Masami Tanaka
Journal:  Rinsho Shinkeigaku       Date:  2010-08

8.  Detection of autoantibodies against NMDA-type glutamate receptor in a patient with recurrent optic neuritis and transient cerebral lesions.

Authors:  N Ishikawa; G Tajima; S Hyodo; Y Takahashi; M Kobayashi
Journal:  Neuropediatrics       Date:  2007-10       Impact factor: 1.947

9.  Anti-myelin oligodendrocyte glycoprotein antibody neuritis optica following anti-NMDA receptor encephalitis.

Authors:  Koji Yokoyama; Mutsuki Hori; Akira Yoshida
Journal:  Pediatr Int       Date:  2016-09       Impact factor: 1.524

10.  Optic neuritis associated with anti-NMDA receptor antibody in the remission phase of anti-NMDA receptor encephalitis.

Authors:  Xingyu Liu; Mohan Giri; Weihao Ling; Tingsong Li
Journal:  Neurol India       Date:  2020 Mar-Apr       Impact factor: 2.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.